U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H26N2O6
Molecular Weight 438.473
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JTE-907

SMILES

CCCCCOC1=C(OC)C=CC2=C1NC(=O)C(=C2)C(=O)NCC3=CC=C4OCOC4=C3

InChI

InChIKey=GRAJFFFXJYFVOC-UHFFFAOYSA-N
InChI=1S/C24H26N2O6/c1-3-4-5-10-30-22-19(29-2)9-7-16-12-17(24(28)26-21(16)22)23(27)25-13-15-6-8-18-20(11-15)32-14-31-18/h6-9,11-12H,3-5,10,13-14H2,1-2H3,(H,25,27)(H,26,28)

HIDE SMILES / InChI

Molecular Formula C24H26N2O6
Molecular Weight 438.473
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24445310 | https://www.ncbi.nlm.nih.gov/pubmed/16824511

JTE-907 is selective high-affinity cannabinoid CB2 receptor inverse agonist. JTE-907 showed a concentration-dependent increase of forskolin-stimulated cAMP production in CHO cells expressing human and mouse CB2 in vitro. In mice model of atopic dermatitis, JTE-907 suppresses spontaneous itch-associated responses of NC mice without adverse effects such as weight loss.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
25.1 nM [IC50]
2370.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
2009 Sep
Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.
2013 Feb
Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
2013 Mar
Patents

Sample Use Guides

The anti-pruritic activity of JTE-907 was studied in NC mice: 1 and 10 mg/kg/day for 20 days
Route of Administration: Oral
CHO cells expressing CB receptors were harvested and cultured at a density of 1 3 10^4 cells/well in 96-well culture plate. After 24-h culture at 37°C, cells were washed with phosphatebuffered saline and incubated at 37°C for 10 min in HEPES buffer [137 mM NaCl, 4.5 mM KCl, 1.2 mM MgCl2, 1 mM CaCl2 x 2H2O, 20 mM HEPES, and 10 mM D-(+)-glucose at pH 7.4] containing 0.25 mM Ro20-1724 in the presence or absence of JTE-907 (0.1nM-100mkM). Cells were then incubated with 5 mM forskolin at 37°C for 15 min, followed by the addition of ice-cold 2.5% dodecyltrimethylammonium bromide (Amersham Pharmacia Biotech, Piscataway, NJ) to stop the reaction. The wells were agitated for 60 min at room temperature. cAMP concentration in the medium of each well was measured by enzyme immunoassay kit
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:36:13 UTC 2023
Edited
by admin
on Sat Dec 16 19:36:13 UTC 2023
Record UNII
DAV3Q7SNOL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JTE-907
Common Name English
3-QUINOLINECARBOXAMIDE, N-(1,3-BENZODIOXOL-5-YLMETHYL)-1,2-DIHYDRO-7-METHOXY-2-OXO-8-(PENTYLOXY)-
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-JTE-907
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
Code System Code Type Description
FDA UNII
DAV3Q7SNOL
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
PRIMARY
EPA CompTox
DTXSID00101001
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
PRIMARY
CAS
282089-49-0
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
PRIMARY
WIKIPEDIA
JTE-907
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
PRIMARY
PUBCHEM
9867770
Created by admin on Sat Dec 16 19:36:13 UTC 2023 , Edited by admin on Sat Dec 16 19:36:13 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY